Stock Region Penny Picks
Stock Region Penny Picks Newsletter - Wednesday, September 25th, 2024.
Stock Region Penny Picks Newsletter - Wednesday, September 25th, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is intended for informational purposes only and should not be considered as financial or investment advice. Please consult with a financial advisor before making any investment decisions.
Recent Market Highlights:
$OCTO: Eightco has released its strategic plan for 2025, forecasting an impressive $100 million in revenue.
$BREA: Brera Holdings is making moves in the sports sector, signing an exclusive letter of intent to acquire an Italian Serie B football club.
$AIMD: Ainos, Inc. has received IRB approval for its HIV-Oral Warts clinical trial at National Taiwan University Hospital, spotlighting its FDA-designated orphan drug, VELDONA.
$BNRG: Brenmiller Energy has established a joint venture aimed at scaling the adoption of its bGenâ„¢ technology across Europe.
$KULR: KULR has secured an expanded contract with the U.S. Army worth $2.4 million, setting the stage for the production of its KULR ONE Guardian Battery in 2025.
$OKLO: Oklo has finalized an agreement with the Department of Energy, advancing to the next phase of its siting process.
$CERO: CERo Therapeutics, Inc. announced new financing and provided an update on its investigational new drug application for CER-1236.
$BNZI: Banzai has announced a $5 million private placement, priced at-the-market under Nasdaq rules.
$CAPR: Maxim Group maintains a buy rating on Capricor Therapeutics, raising its price target to $25.
$OMH: Ohmyhome has reported a remarkable 106% revenue growth in the first half of 2024, achieving S$4.5 million (US$3.3 million).
$NCNA: NuCana has been granted a composition-of-matter patent for NUC-7738 in the United States.
$TBIO: Telesis Bio is collaborating with Beckman Coulter Life Sciences to innovate DNA and mRNA synthesis.
$VVPR: VivoPower is merging with Future Automotive Solutions and Technologies (FAST), forming a US$1.13bn entity, aiming to benefit from $21bn government clean energy investment programs.
Disclaimer: This newsletter is intended for informational purposes only and should not be considered as financial or investment advice. Please consult with a financial advisor before making any investment decisions.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net
